Detail Infos CC-92480 (cereblon modifying agent) in combination with standard treatments
Universitätsklinikum FreiburgID: 477
EntitätMultiples Myelom
Therapie-Linie
R/R
Altersgruppe
≥18
Phase
I/II
Ein- / Auschlusskriterien
- has received 1-4 prior treatments (prior lines and In/Ex-criteria depending on cohorts)
- prior treatment with a lenalidomide-containing regimen for at least 2 consecutive cycles
- achieved response (minimal reponse [MR] or better) to at least 1 prior treatment regimen
Arzt
Prof. Dr. R. Wäsch: (Ralph.Waesch@uniklinik-freiburg.de)
Study Nurse
Rainer Lohmüller: Telefon 0761/270 32907; (rainer.lohmueller@uniklinik-freiburg.de)